Ann Coloproctol.
2019 Oct;35(5):225-226. 10.3393/ac.2019.10.11.
Factors Affecting Surgical Treatment With Infliximab Therapy in Perianal Fistula With Crohn Disease
- Affiliations
-
- 1Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. iamleejong@amc.seoul.kr
- KMID: 2464334
- DOI: http://doi.org/10.3393/ac.2019.10.11
Abstract
- No abstract available.
MeSH Terms
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Surgical treatment of perianal fistula in Crohn's disease
- Adalimumab or infliximab: which is better for perianal fistula in Crohn's disease?
- Clinical efficacy of adalimumab versus infliximab and the factors associated with recurrence or aggravation during treatment of anal fistulas in Crohn's disease
- Evaluation of a Seton Procedure Combined With Infliximab Therapy (Early vs. Late) in Perianal Fistula With Crohn Disease
- Treatment Strategy for Perianal Fistulas in Crohn Disease Patients: The Surgeon’s Point of View
